Literature DB >> 17538658

Temporal expression of Mycobacterium smegmatis respiratory terminal oxidases.

James A Megehee1, Michael D Lundrigan.   

Abstract

Terminal oxidases provide the final step in aerobic respiration by reducing oxygen. The mycobacteria possess two terminal oxidases: a cytochrome c aa3 type and a quinol bd type. We previously isolated a bd-type oxidase knockout mutant of Mycobacterium smegmatis that allowed for functional analysis of the aa3 type without the contribution of bd-type activity. Growth of M. smegmatis LR222 and JAM1 (LR222bd::kan) was monitored and the cytochrome content at different time points examined. No difference in aerobic growth was observed between M. smegmatis LR222 and JAM1. Membranes were obtained from these cultures and the oxidase concentrations were calculated from their spectrum. Although the mutant was producing only one oxidase type, this oxidase did not reach wild-type levels of expression, suggesting an additional mechanism for energizing the membrane. Moreover, the concentration of both oxidases in the wild-type strain dropped when cultures entered stationary phase, which was not the case for the aa3-type oxidase of the mutant strain. This oxidase remained at a constant concentration post mid-log phase. RNase protection assays also demonstrated late growth phase dependent message expression of the bd oxidase and that the subunits I and II genes were cotranscribed as an operon.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17538658     DOI: 10.1139/W06-140

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  3 in total

1.  Hypoxia-activated cytochrome bd expression in Mycobacterium smegmatis is cyclic AMP receptor protein dependent.

Authors:  Htin Lin Aung; Michael Berney; Gregory M Cook
Journal:  J Bacteriol       Date:  2014-06-16       Impact factor: 3.490

Review 2.  Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?

Authors:  Sapna Bajeli; Navin Baid; Manjot Kaur; Ganesh P Pawar; Vinod D Chaudhari; Ashwani Kumar
Journal:  Front Cell Infect Microbiol       Date:  2020-11-23       Impact factor: 5.293

3.  Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.

Authors:  Safaa M Kishk; Kirsty J McLean; Sakshi Sood; Mohamed A Helal; Mohamed S Gomaa; Ismail Salama; Samia M Mostafa; Luiz Pedro S de Carvalho; Andrew W Munro; Claire Simons
Journal:  Bioorg Med Chem       Date:  2019-02-27       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.